Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Veterinary Pharmacology and Therapeutics|May 21, 2003
Interactions of xylazine and detomidine with alpha2-adrenoceptors in brain tissue from cattle, swine and ratsK Törneke, U Bergström, A Neil
Rheumatology (Oxford, England)|August 26, 1999
Extra-articular rheumatoid arthritis: prevalence and mortalityC Turesson, L Jacobsson, U Bergström
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 25, 2008
Fracture mechanisms and fracture pattern in men and women aged 50 years and older: a study of a 12-year population-based injury register, Umeå, SwedenU Bergström, U Björnstig, H Stenlund, et al.
Scandinavian Journal of Rheumatology|December 29, 2000
Predictors of extra-articular manifestations in rheumatoid arthritisC Turesson, L Jacobsson, U Bergström, et al.
Journal of Drug Targeting|February 11, 2003
Drug targeting to the brain: transfer of picolinic acid along the olfactory pathwaysU Bergström, A Franzén, C Eriksson, et al.
Journal of Fish Biology|October 5, 2013
Effects of a large northern European no-take zone on flatfish populationsA-B Florin, U Bergström, D Ustups, et al.
Scandinavian Journal of Rheumatology|June 25, 1999
Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978U Bergström, C Book, Y Lindroth, et al.
Neurotoxicology|July 28, 2007
Differential gene expression in the olfactory bulb following exposure to the olfactory toxicant 2,6-dichlorophenyl methylsulphone and its 2,5-dichlorinated isomer in miceU Bergström, J A Olsson, T R Hvidsten, et al.
Journal of Neurochemistry|April 1, 1990
Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy casesP Wester, U Bergström, A Eriksson, et al.
Scandinavian Journal of Rheumatology|May 13, 2016
Multiplex cytokine analyses in patients with rheumatoid arthritis require use of agents blocking heterophilic antibody activityP Olsson, E Theander, U Bergström, et al.
Pageof 3